The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

(WXYZ) — The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. A new ...

A dad died just days after using a weight-loss jab so he could ‘confidently walk his daughter down the aisle’, and now his family are demanding answers. Back in 2022, Tim Ramsay decided he wanted to ...

The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?

GLP-1s have gone so far as to disrupt the food, clothing, and, of course, weight-loss industries. Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy ...

Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive ...

Forget the walk-off grand slam off the bat of a hobbled Freddie Freeman. Forget the questionable bullpen decisions, such as using Nestor Cortes in a high-leverage spot with the game on the line in ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found. The ...